Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression-Reference-Cited by-同舟云学术

Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression

Published:2018-05-14 Issue:6 Volume:128 Page:2487-2499
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Kawano Yawara,Zavidij Oksana,Park Jihye,Moschetta Michele,Kokubun Katsutoshi,Mouhieddine Tarek H.,Manier Salomon,Mishima Yuji,Murakami Naoka^ORCID,Bustoros Mark^ORCID,Pistofidis Romanos Sklavenitis,Reidy Mairead,Shen Yu J.,Rahmat Mahshid,Lukyanchykov Pavlo,Karreci Esilida Sula,Tsukamoto Shokichi^ORCID,Shi Jiantao^ORCID,Takagi Satoshi,Huynh Daisy,Sacco Antonio,Tai Yu-Tzu^ORCID,Chesi Marta^ORCID,Bergsagel P. Leif^ORCID,Roccaro Aldo M.,Azzi Jamil^ORCID,Ghobrial Irene M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/88169/files/pdf

Reference61 articles.

1. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

2. Immune checkpoint blockade in hematologic malignancies

3. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies;Landgren;Hematology Am Soc Hematol Educ Program,2013

5. Immunosurveillance and therapy of multiple myeloma are CD226 dependent

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment;Biomarker Research;2024-09-03

2. Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment;Frontiers in Oncology;2024-07-17

3. Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications;Blood Advances;2024-06-11

4. Identification of potential immune-related mechanisms related to the development of multiple myeloma;Chinese Medical Journal;2024-06-06

5. RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma;Aging;2024-03-01